InflaRx NV (IFRX) is not a good buy for a long-term beginner investor at this time. The company's financial performance is significantly declining, with sharp drops in revenue, net income, and EPS. Additionally, there are no strong positive catalysts or trading signals to support a buy decision. The technical indicators and options data suggest a neutral to slightly bearish sentiment, and the lack of recent news or influential trading activity further weakens the case for investment.
The MACD is slightly positive at 0.0113 but contracting, indicating weakening momentum. The RSI is neutral at 60.485, and moving averages are converging, suggesting no clear trend. Key support and resistance levels are at 0.85 and 0.949, respectively, with the stock trading pre-market at 0.93, close to resistance. Overall, the technical indicators do not strongly support a buy decision.

Hedge funds have increased their buying activity by 425.33% over the last quarter, which may indicate some institutional interest.
The company's financial performance has significantly declined in the latest quarter, with revenue dropping by -80.75% YoY, net income down -29.73% YoY, and EPS down -40% YoY. Additionally, there is no recent news, analyst updates, or influential trading activity to provide support for the stock.
In Q3 2025, revenue dropped to 23,830 (-80.75% YoY), net income fell to -12,261,089 (-29.73% YoY), EPS decreased to -0.18 (-40% YoY), and gross margin declined to 98.6 (-37.83% YoY). These figures indicate significant financial struggles.
No recent updates on analyst ratings or price targets are available for IFRX.